TherapeuticsMD TXMD
NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Notes Payables (2010 - 2012)

Updated

TherapeuticsMD's Notes Payables came in at $2.1 million for Q3 2012, up 601.6% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Notes Payables (2010 - 2012) Analysis & Trends

At the end of FY2011, TherapeuticsMD's Notes Payables was $200,000, down 63.2% from FY2010.

  • Going back by year, Notes Payables was $543,531 in FY2010.
  • Business Quant data shows TXMD's Notes Payables at $299,220 (Q2 2012), $1.35 million (Q1 2012) and $200,000 (Q4 2011) in the three quarters before Q3 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 TherapeuticsMD 21.67 Mn 21.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 2.10 Mn
Jun 30, 2012 299,220.00
Mar 31, 2012 1.35 Mn
Dec 31, 2011 200,000.00
Jun 30, 2011 99,000.00
Dec 31, 2010 543,531.00
API Access

TherapeuticsMD Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TXMD&period=max&api_key=YOUR_API_KEY